Tango Therapeutics, Inc. (TNGX) Revenue History
Tango Therapeutics, Inc. (TNGX) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2020-12-31 | $7.66M |
| 2021-12-31 | $37.04M |
| 2022-12-31 | $24.86M |
| 2023-12-31 | $36.53M |
| 2024-12-31 | $42.07M |
| 2025-12-31 | $62.38M |
How TNGX compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| SPRO | Spero Therapeutics Inc. | $66.80M |
| NERV | — | $41.18M |
| EYPT | EyePoint Pharmaceuticals Inc. | $31.37M |
| ALEC | Alector Inc. | $21.05M |
| NMTC | NeuroOne Medical Technologies Corporation | $9.10M |
These are five companies in the same sector as TNGX with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Tango Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("TNGX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TNGX | $25.47 | +2.83% | 3.17M |
| 3 | ||||
| 4 | ||||
| 5 |